Unknown

Dataset Information

0

Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial.


ABSTRACT: The demonstration of batch-to-batch consistency to confirm the reliability of the manufacturing process has become a mandatory step in vaccine development. This is a post-hoc analysis aimed to provide more solid evidence on the immunogenicity and consistency of 3 consecutive batches of a novel inactivated enterovirus 71 (EV71) vaccine. In total 10?245 healthy Chinese children aged 6-35 months had been recruited and randomized to receive one of 3 batches of EV71 vaccine or placebo according to a two-dose immunization schedule in a phase 3 clinical trial. Blood samples were taken just before and 28 days after vaccinations for serological tests of EV71 neutralizing antibody (NTAb) titer from the subjects. Among them, 7263 (70.9%) subjects with seronegative EV71 NTAb at baseline and the data of serological tests post-vaccination available were included for the analysis. The results showed that EV71 vaccine elicited high geometric mean titers (GMTs) of 407.0 U/mL (95% CI, 373.5-443.6) for batch 1, 468.1 U/mL (95% CI, 432.2-507.0) for batch 2, and 520.6 U/mL (95% CI, 481.2-563.3) for batch 3. The two-sided 95% confidence intervals (CIs) for the GMT ratios between each pair of vaccine batches were all within an interval of [0.67, 1.5]. Subjects who received EV71 vaccines demonstrated significant higher GMTs than those received placebos did (P<0.001). In terms of incidence of both local and general adverse reactions, no differences were found among 3 vaccine batches and placebos. EV71 vaccine was highly immunogenic in children, and the 3 consecutive batches were well consistent.

SUBMITTER: Chen YJ 

PROVIDER: S-EPMC4896521 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial.

Chen Yi-Juan YJ   Meng Fan-Yue FY   Mao Qunying Q   Li Jing-Xin JX   Wang Hua H   Liang Zheng-Lun ZL   Zhang Yun-Tao YT   Gao Fan F   Chen Qing-Hua QH   Hu Yuemei Y   Ge Zi-Jun ZJ   Yao Xin X   Guo Hui-Jie HJ   Zhu Feng-Cai FC   Li Xiu-Ling XL  

Human vaccines & immunotherapeutics 20140314 5


The demonstration of batch-to-batch consistency to confirm the reliability of the manufacturing process has become a mandatory step in vaccine development. This is a post-hoc analysis aimed to provide more solid evidence on the immunogenicity and consistency of 3 consecutive batches of a novel inactivated enterovirus 71 (EV71) vaccine. In total 10 245 healthy Chinese children aged 6-35 months had been recruited and randomized to receive one of 3 batches of EV71 vaccine or placebo according to a  ...[more]

Similar Datasets

| S-EPMC4962949 | biostudies-literature
| S-EPMC3889509 | biostudies-literature
| S-EPMC4157806 | biostudies-literature
| S-EPMC3820736 | biostudies-literature
| S-EPMC4574357 | biostudies-literature
| S-EPMC8018479 | biostudies-literature
| S-EPMC2798416 | biostudies-literature
| S-EPMC4501189 | biostudies-literature
| S-EPMC4543551 | biostudies-literature
| S-EPMC5659012 | biostudies-literature